High incidence of osteoporosis in thalassaemia major

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 975-977

  Jensen, C E ^a   Tuck, S M ^b   Agnew, I E ^b   Koneru, S ^b   Morris, R W ^b   Yardumian, A ^c   Prescott, E ^d   Hoffbrand, A V ^b   Wonke, B ^d  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^d WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE DENSITY; BONE MINERAL; CONFERENCE PAPER; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATING AGENTS; CHILD; FEMALE; FERRITINS; HUMANS; MALE; OSTEOPOROSIS; TIME FACTORS;

EID: 0032413344     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Jensen CE, Tuck SM, Old J, Morris RW, Yardumian A, De Sanctis V, Hoffbrand AV, Wonke B. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol 1997; 59: 76-81.
2. Riggs BL, Melton U. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899-901.
3. Krane SM, Holick MF. Metabolic bone disease. In: Braunwald E, et al., eds. Harrison's Principles of Internal Medicine, 11th Ed. New York: McGraw-Hill Book Company, 1987; 1889-1894.